Sandy Draper

Stock Analyst at Guggenheim

(2.93)
# 1,438
Out of 4,853 analysts
119
Total ratings
58.33%
Success rate
19.74%
Average return

Stocks Rated by Sandy Draper

Medpace Holdings
Jul 24, 2024
Maintains: Buy
Price Target: $464$432
Current: $293.58
Upside: +47.15%
IQVIA Holdings
Feb 15, 2024
Downgrades: Neutral
Price Target: n/a
Current: $147.37
Upside: -
Charles River Laboratories International
Feb 15, 2024
Downgrades: Neutral
Price Target: n/a
Current: $141.20
Upside: -
Evolent Health
Nov 14, 2023
Maintains: Hold
Price Target: $36$34
Current: $8.19
Upside: +315.14%
GoodRx Holdings
Aug 10, 2023
Maintains: Buy
Price Target: $8$10
Current: $4.22
Upside: +136.97%
Doximity
Aug 9, 2023
Downgrades: Neutral
Price Target: n/a
Current: $57.34
Upside: -
The Oncology Institute
Jun 16, 2023
Maintains: Buy
Price Target: $3$2
Current: $2.79
Upside: -28.32%
ICON Public Limited Company
Apr 28, 2023
Maintains: Buy
Price Target: $271$263
Current: $134.82
Upside: +95.07%
agilon health
Mar 6, 2023
Maintains: Buy
Price Target: $21$30
Current: $2.10
Upside: +1,328.57%
HealthEquity
Dec 7, 2022
Maintains: Buy
Price Target: $89$94
Current: $112.70
Upside: -16.59%
Upgrades: Neutral
Price Target: n/a
Current: $6.93
Upside: -
Maintains: Buy
Price Target: $36$51
Current: $22.80
Upside: +123.73%
Maintains: Buy
Price Target: $143$129
Current: $165.51
Upside: -22.06%
Maintains: Buy
Price Target: $84$55
Current: $26.98
Upside: +103.85%
Maintains: Buy
Price Target: $226$168
Current: $54.38
Upside: +208.94%
Initiates: Hold
Price Target: $12
Current: $52.77
Upside: -77.26%
Maintains: Hold
Price Target: $33$38
Current: $23.13
Upside: +64.29%
Initiates: Buy
Price Target: $50
Current: $5.06
Upside: +888.14%
Initiates: Buy
Price Target: $65
Current: $7.13
Upside: +811.64%
Maintains: Buy
Price Target: $30$36
Current: $3.84
Upside: +837.50%
Maintains: Buy
Price Target: $175$167
Current: $289.94
Upside: -42.40%
Upgrades: Buy
Price Target: n/a
Current: $1.47
Upside: -
Initiates: Buy
Price Target: $63
Current: $16.50
Upside: +281.93%